Keyword: Bavarian Nordic

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

Bavarian Nordic is building a new fill-finish manufacturing line in Denmark to bring Imvamune manufacturing in-house.

Initial lab work suggests that the Ebola Zaire strain—the one targeted by Merck's rVSV-ZEBOV—is likely the cause of this outbreak.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

BN will use its proprietary MVA-BN platform to develop a vaccine against three strains of the potentially deadly mosquito-borne virus.

Here's some other vaccine news of note for the week.

BN's cancer vaccine CV301 is already under evaluation with Keytruda in NSCLC and with Tecentriq in bladder cancer.

With a second set of phase 3 data in hand for smallpox vaccine Imvamune, Bavarian Nordic is gearing up for a U.S. filing later this year.